National Monitoring Standards for RWHAP Part A Recipients
Resource updated 08/21/2023
Resource updated 08/21/2023
Resource updated 06/09/2022
Resource updated 08/03/2023
Resource updated 09/19/2023
Resource updated 09/19/2023
Resource updated 09/19/2023
Resource (Conference Presentation) updated 09/14/2023
Resource updated 08/03/2023
Resource updated 09/19/2023
Resous sa a ofri eksplikasyon sou Medicare pou konsomatè yo pandan y ap konsidere enskripsyon an. Konsomatè yo pral revize diferan pati Medicare (Pati A, B, C, ak D) epi konprann diferans ki genyen ant plan Original Medicare ak Medicare Advantage la.
Resource updated 09/19/2023
Resource updated 09/19/2023
Resource updated 05/16/2024
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource updated 05/17/2024
Resource updated 06/13/2023
Resource updated 10/09/2023
Resource updated 06/13/2023
Barriers and facilitators to HCV treatment during the DAA era for the understudied and high-risk population of HIV/HCV co-infected patients who delay or do not consent to treatment, and interventions for increasing DAA treatment uptake.
Resource (Conference Presentation) updated 09/14/2023
Overview of the RWHAP, Emergency Relief Funding, and EHE legislation.
Resource (Conference Presentation) updated 09/14/2023